rxstat › Shortages › Quizartinib

Quizartinib (Vanflyta) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Oct 28, 2026

Quizartinib has no current shortage reported in Canada. It has been in shortage before; the history is below.
Products affected
0 / 2
Reports on file
2

Reports by product

The DIN is printed on your prescription label.

Resolved
VANFLYTA
17.7MG · TABLET · DAIICHI SANKYO PHARMA CANADA LIMITED
DIN 02558351 · ended Oct 27, 2026 · Interruption of Supply. Foreign authorized product is available.
Resolved
VANFLYTA
26.5MG · TABLET · DAIICHI SANKYO PHARMA CANADA LIMITED
DIN 02558378 · ended Oct 27, 2026 · Interruption of supply. Foreign authorized product is available.

What's happening

There are no active shortage reports for Quizartinib. Health Canada has 2 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Recent changes

Common questions

When will Quizartinib be back in stock in Canada?

Quizartinib has no active shortage; supply is normal per Health Canada reports.

Why is Quizartinib in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.